HCW Biologics Inc. (HCWB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, HCW Biologics Inc. reported revenue of $54.2K, down 97.9% from the prior year. The company ran a net loss, with a net margin of -14677.1% and a gross margin of 20.0%. It held $24.52M in total assets against $21.76M in total liabilities.
Key ratios (FY2025)
20.0%
Gross margin
-24270.7%
Operating margin
-14677.1%
Net margin
-287.9%
Return on equity
-97.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $54.2K | $2.57M | $2.84M | $6.72M | $0 | $4.10M | — |
| Cost of Revenue | $43.4K | $1.61M | $2.28M | $4.14M | $0 | — | — |
| Gross Profit | $10.8K | $959.4K | $560.4K | $2.59M | $0 | — | — |
| Operating Income | -$13.16M | -$29.46M | -$25.72M | -$15.08M | -$13.37M | -$5.82M | — |
| Net Income | -$7.96M | -$30.02M | -$24.99M | -$14.90M | -$12.86M | -$5.80M | — |
| EPS (Diluted) | $-10.63 | $-30.96 | $-0.70 | $-0.42 | $-0.69 | — | — |
| Total Assets | $24.52M | $30.24M | $28.51M | $46.81M | $53.51M | $15.40M | — |
| Total Liabilities | $21.76M | $37.01M | $15.05M | $9.38M | $2.32M | — | — |
| Shareholders' Equity | $2.76M | -$6.77M | $13.46M | $37.43M | $51.19M | -$16.72M | -$9.68M |
| Cash & Equivalents | $1.95M | $4.67M | $3.60M | $22.33M | $11.73M | $8.46M | $7.36M |
| Operating Cash Flow | -$13.39M | -$14.23M | -$22.51M | -$10.39M | -$10.98M | -$10.43M | — |
| Capital Expenditures | $0 | $261.6K | $6.20M | $10.28M | $47.3K | $186.7K | — |
| Shares Outstanding | 2.10M | 969.8K | 35.93M | 35.82M | 18.77M | — | — |